News: Latest Clinical Research from Caris Life Sciences

October 18, 2018June 28, 2019

Meet the Expert at ESMO 2018

Heading to Germany? The European Society for Medical Oncology is the leading European professional organisation for medical oncology. The ESMO...

June 14, 2018June 28, 2019

New research reveals certain mutations detected by plasma genotyping in NSCLC patients due to clonal haematopoiesis, not tumour

The large amount of enthusiasm behind the potential applications of plasma cell-free DNA (cfDNA) analysis appears to have outpaced our...

December 14, 2017June 28, 2019

New research highlights superior clinical benefit and lower utility cost of Caris Molecular Intelligence

New research1 presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) from 4th-8th November 2017 in Glasgow, Scotland...

December 14, 2017June 28, 2019

New research compares Caris Molecular Intelligence and Foundation One-guided treatment costs

New research1 presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting from 4th-8th November 2017 in Glasgow,...

November 21, 2017June 28, 2019

New research from ESMO highlights clinical benefit of Caris Molecular Intelligence

The progression-free survival (PFS) of patients with heavily pre-treated rare or refractory cancer usually declines with every new line of...

October 04, 2017June 28, 2019

NICE briefing on Caris Molecular Intelligence

The National Institute for Health and Care Excellence (NICE) has released a medical technology innovation briefing on Caris Molecular Intelligence...

July 25, 2017June 28, 2019

Molecular profiling explained by Dr David Spetzler: An interview

NH: Hello and thank you for tuning into the program. I’m your host Neil Howard here on Health Professional Radio....

July 18, 2017June 28, 2019

Guardant Health files lawsuit against Foundation Medicine

An original complaint against Foundation Medicine Inc. has recently been filed by Guardant Health Inc. Guardant seeks to recover damages and...

July 13, 2017June 28, 2019

First results from the AURORA pilot study for molecular screening of patients with advanced breast cancer

In April 2014, OncoDNA, a clinical NGS provider affiliated with the Institute of Pathology and Genetics in Gosselies, Belgium, announced...

July 04, 2017June 28, 2019

Measuring prevalence of oncogenic homologous recombination pathway mutations across 53,000 tumours

Results of a molecular profiling analysis to identify the frequency of Homologous Recombination Deficiencies (HRD) from approximately 53,000 tumours have...